| Ytd | -72.62% | |
| 1y | -87.71% |
| Open | 0.88 | Prev Close | 0.86 | Low | 0.86 | High | 0.89 | Mkt Cap | 3.08M |
| Vol | 31.84K | Avg Vol | 294.15K | EPS | -4.09 | P/E | N/A | Forward P/E | -0.37 |
| Beta | 0.56 | Short Ratio | 0.02 | Inst. Own | 6.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.98 | 200-d Avg | 2.08 | 1yr Est | 12.00 |
PRFX News
Gainers Prime Medicine (NASDAQ:PRME) shares increased by 13.0% to $3.47 during Thursday's after
Gainers Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 14.1% to $4.68 during Wednesday
IEA projects global data center electricity consumption to roughly double to 950 TWh by 2030, with c
PainReform Ltd. (NASDAQ: PRFX - Get Free Report) was the recipient of a large drop in short interest
PRF Technologies Ltd. (Nasdaq: PRFX) ("PRF" or the "Company") today announced its pl
New structure designed to enable direct strategic investment, partnerships, and commercial collabora
FDA cleared the IND for OcuRing™-K, enabling a U.S. multi-center Phase II trial in cataract surgery
Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular
First-Half 2026 and Recent Highlights:Raised $10 million through the Company's equity line facil
Interim CEO Efraim Cohen-Arazi Details $10 Million in New Capital, LayerBio's Preparations for the P
TEL AVIV, Israel, July 21, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or t
Battery-to-Revenue Intelligence is a new capability designed to extend the platform’s optimization w
New Capability Builds on Recently Completed Real-World Validation of DeepSolar Predict™ as the Solut
The validation applied real-world historical weather data, renewable energy production records and m
Validation Applied Utility-Scale Renewable Production, Weather and Market Data Across Day-Ahead and
PRF Technologies Ltd. (Nasdaq: PRFX) ("PRF" or the "Company"), a clinical-stage spec
Additional data reported by an independent research firm show comparable analgesic efficacy to ZYNRE
On June 18, 2026, PRF Technologies Ltd. (the "Company") entered into a Standby Equity Purcha
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
PRF Technologies (NASDAQ: PRFX) stock falls sharply Monday morning. Read why analysts see this as a
PRF Technologies (NASDAQ:PRFX) stock falls sharply Monday morning. Read why analysts see this as a m
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce
Dell beats massive estimates, IBM launches $5B Project Lightwell, CrowdStrike expands cyber insuranc
Dell Technologies Inc. (DELL) stock rises 38.7% in premarket trading after strong fiscal Q1 sales an
PRF Technologies Ltd. shares surged 186.22% in after-hours trading after advancing its AI-driven ene
Platform builds on NVIDIA Connect participation and previously announced weather-domain patent filin
PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine desi
Ropivacaine-only, NSAID-free formulation leverages a long-acting local anesthetic with a favorable s
Milestone supports advancement of PRF's drop-less ocular drug-delivery platform into next-stage U.S.
PRF Technologies gains FDA IND clearance for OcuRing-K, advancing Phase 2 trial plans for drop-less
PRF Technologies outlines 2025 progress, with OcuRing-K ocular drug-delivery advancement and AI sola
PainReform Ltd. (NASDAQ: PRFX - Get Free Report) was the target of a large decrease in short interes
LayerBio's OcuRing™-K program and broader ocular platform strengthen PRF's healthcare growth
LayerBio's OcuRing™-K program and broader ocular platform strengthen PRF's healthcare growth strateg
PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced a comme
TEL AVIV, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or
Agreement Initiates Data-Driven Technical Due Diligence of an Operational, Utility-Scale Solar Asset